Back @entity158 in adolescents with XXXX : epidemiological study for 43,630 pupils in Niigata City, Japan.

@entity615 @entity2112 @entity1635 @entity158
There have been a few studies regarding detail of @entity615 in adolescents with @entity2112 ( @entity2112 ) as prevalence, location, and severity. The condition of @entity615 in adolescents with @entity2112 was clarified based on a cross-sectional study using a questionnaire survey, targeting a total of 43,630 pupils, including all elementary school pupils from the fourth to sixth grade (21,893 pupils) and all junior high pupils from the first to third year (21,737 pupils) in Niigata City (population of 785,067), Japan. 32,134 pupils were determined to have valid responses (valid response rate: 73.7%). In Niigata City, pupils from the fourth grade of elementary school to the third year of junior high school are screened for @entity1635 every year. This screening system involves a three-step survey, and the third step of the survey is an imaging and medical examination at the Niigata University Hospital. In this study, the pupils who answered in the questionnaire that they had been advised to visit Niigata University Hospital after the school screening were defined as @entity1635 group (51 pupils; 0.159%) and the others were defined as No @entity1635 group (32,083 pupils). The point and lifetime prevalence of @entity615 , the duration, the recurrence, the severity and the location of @entity615 were compared between these groups. The severity of @entity615 was divided into three levels (level 1 no limitation in any activity; level 2 necessary to refrain from participating in sports and physical activities, and level 3 necessary to be absent from school). The point prevalence was 11.4% in No @entity1635 group, and 27.5% in @entity1635 group. The lifetime prevalence was 32.9% in No @entity1635 group, and 58.8% in @entity1635 group. According to the gender- and school-grade-adjusted odds ratios (OR), @entity1635 group showed a more than twofold elevated odds of @entity615 compared to No @entity1635 group irrespective of the point or lifetime prevalence of @entity615 (OR, 2.29; P = 0.009 and OR, 2.10; P = 0.012, respectively). @entity1635 group experienced significantly more severe @entity158 , and of a significantly longer duration with more frequent recurrences in comparison to No @entity1635 group. @entity1635 group showed significantly more @entity615 in the @entity615 in comparison to No @entity1635 group. These findings suggest that there is a relationship between @entity158 around the right scapula in @entity1635 group and the right rib hump that is common in @entity2112 .
